CoChat

Retinoblastoma protein partners

Erick J. Morris, Nicholas J. Dyson · 2001 · Advances in Cancer Research

The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.

Abstract

Studies of the retinoblastoma gene (Rb) have shown that its protein product (pRb) acts to restrict cell proliferation, inhibit apoptosis, and promote cell differentiation. The frequent mutation of the Rb gene, and the functional inactivation of pRb in tumor cells, have spurred interest in the mechanism of pRb action. Recently, much attention has focused on pRb's role in the regulation of the E2F transcription factor. However, biochemical studies have suggested that E2F is only one of many pRb-targets and, to date, at least 110 cellular proteins have been reported to associate with pRb. The plethora of pRb-binding proteins raises several important questions. How many functions does pRb possess, which of these functions are important for development, and which contribute to tumor suppression? The goal of this review is to summarize the current literature of pRb-associated proteins.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0065-230x(01)82001-7

Cites

207 of 207 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 207 references

Research works printed but not linked: 66

  1. Abbondanza, 2000, 97, 3130
  2. Adnane, 1995, Oncogene, 10, 381
  3. Akiyama, 1992, 89, 7900
  4. Alberts, 1993, 90, 388
  5. Aprelikova, 1999, 96, 11866
  6. Batsche, 1994, Oncogene, 9, 2235
  7. Bergemann, 1992, Mol. Cell Biol., 12, 1257
  8. Bergemann, 1992, Mol. Cell Biol., 12, 5673
  9. Bhat, 1999, 96, 7859
  10. Brehm, 1998, Nature, 391, 591, 10.1038/35404 · DOI · Paper page
  11. Buyse, 1995, 92, 4467
  12. Chang, 1997, 94, 9040
  13. Chauhan, 1999, Cancer Res., 59, 1192
  14. Chen, 1994, Mol. Cell Biol., 14, 4380
  15. Chen, 1996, 93, 465
  16. Chen, 1995, Cell Growth Differ., 6, 199
  17. Craven, 1995, Cancer Res., 55, 3969
  18. Cress, 1993, Mol. Cell Biol., 13, 6314
  19. Cvekl, 1999, Invest. Ophthalmol. Vis. Sci., 40, 1343
  20. Cziepluch, 1993, Oncogene, 8, 2833
  21. Dick, 2000, Mol. Cell Biol., 20, 3715, 10.1128/MCB.20.10.3715-3727.2000 · doi:10.1128/mcb.20.10.3715-3727.2000 · Paper page
  22. Eberhard, 1999, Cancer Res., 59, 1716s
  23. Ezhevsky, 1997, 94, 10699
  24. Fajas, 2000, 97, 7738
  25. Fattaey, 1993, Oncogene, 8, 3149
  26. Ferreira, 1998, 95, 10493
  27. Hagemeier, 1993, 90, 1580
  28. Hall, 1993, Oncogene, 8, 1377
  29. He, 2000, Oncogene, 19, 3233
  30. Horton, 1995, Cell Growth Differ., 6, 395
  31. Hu, 1992, Mol. Cell Biol., 12, 971
  32. Ivey-Hoyle, 1993, Mol. Cell Biol., 13, 7802
  33. Kelly, 1998, 95, 2535
  34. Kennedy, 2000, Genes Dev.
  35. Kim, 1991, 88, 3052
  36. Kim, 1994, Mol. Cell Biol., 14, 7256
  37. Kitagawa, 1992, Oncogene, 7, 1067
  38. Knudson, 1971, 68, 820
  39. Lees, 1993, Mol. Cell Biol., 13, 7813
  40. Leone, 2000, Mol. Cell Biol., 20, 3626, 10.1128/MCB.20.10.3626-3632.2000 · doi:10.1128/mcb.20.10.3626-3632.2000 · Paper page
  41. Mancini, 1994, 91, 418
  42. Martelli, 1994, Oncogene, 9, 3579
  43. Meloni, 1999, 96, 9574
  44. Nevins, 1998, Cell Growth Differ., 9, 585
  45. Nihei, 1993, Cancer Res., 53, 1702
  46. Nuell, 1991, Mol. Cell Biol., 11, 1372
  47. Numata, 1999, Cancer Res., 59, 3741
  48. Otterson, 1993, Oncogene, 8, 949
  49. Ozaki, 1994, Oncogene, 9, 2649
  50. Ruggieri, 1989, 86, 8778
  51. Sellers, 1995, 92, 11544
  52. Shan, 1992, Mol. Cell Biol., 12, 5620
  53. Shao, 1995, 92, 3115
  54. Sterner, 1996, Cell Growth Differ., 7, 53
  55. Tamrakar, 2000, J. Biol. Chem.
  56. Templeton, 1992, Mol. Cell Biol., 12, 435443
  57. Templeton, 1991, 88, 3033
  58. Trouche, 1997, 94, 11268
  59. Udvadia, 1993, 90, 3265
  60. Udvadia, 1995, 92, 3953
  61. Williams, 1992, Oncogene, 7, 423
  62. Witte, 1997, 94, 1212
  63. Wu, 1998, Nucleic Acids Res., 26, 48374845
  64. Yarden, 1999, 96, 4983
  65. Yavuzer, 1995, Oncogene, 10, 123
  66. Zhu, 1997, J. Cell Biochem., 66, 441, 10.1002/(SICI)1097-4644(19970915)66:4<441::AID-JCB3>3.0.CO;2-L · doi:10.1002/(sici)1097-4644(19970915)66:4<441::aid-jcb3>3.0.co;2-l

Cited by

See all 349

Metadata

Authors
Morris, E. J., & Dyson, N. J.
Affiliations
Massachusetts General Hospital (US)
Corresponding author
Nicholas J. Dyson
Venue
Advances in Cancer Research
Publisher
Elsevier
Published
2001
Volume
82
Pages
1-54
ISSN
0065-230X (ISSN-L)
OpenAlex
W1486122524
Cited by
349
References
205
Citations by year
2026: 1 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 7 · 2021: 9 · 2020: 11 · 2019: 9 · 2018: 4 · 2017: 9 · 2016: 9 · 2015: 13 · 2014: 10 · 2013: 10 · 2012: 16
FWCI
54.26
Type
book chapter
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Advances in cancer research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
Keywords
retinoblastoma protein, E2F transcription factors, tumor suppression, cell proliferation, apoptosis, cell differentiation, protein-protein interaction, retinoblastoma gene
MeSH terms
Carrier Proteins, Humans, Transcription Factors, Retinoblastoma Protein, Genes, Retinoblastoma, Cell Cycle Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Retinoblastoma protein partners. https://app.cochat.ai/papers/10.1016/s0065-230x(01)82001-7
The paper
Morris, E. J., & Dyson, N. J. (2001). Retinoblastoma protein partners. Advances in Cancer Research. https://doi.org/10.1016/s0065-230x(01)82001-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.